The fund was raised at a concessional 5.72% rate, which includes the hedging cost, IIFL Home Finance chief executive Monu Ratra told ET. Its average cost of funds is 8.4%. The deal marks the growing confidence shown by overseas investors on India's affordable housing space, which is growing rapidly with government focus.

IIFL Finance, the non-banking finance arm of IIFL, has raised $175 million through a three-year external commercial borrowing (ECB) from lenders including HSBC and Bank of Baroda. The loan, priced at SOFR +200 basis points, will be used for onward lending purposes. $75 million was raised from HSBC and $50 million from Bank of Baroda, with the remaining amount secured from other lenders. IIFL Finance aims to reduce its cost of borrowing and diversify its borrowing sources with these funds.

Investors Shah Rakesh and Satpal Khattar sold shares worth Rs 697 crore and Rs 510 crore, respectively in Eric Lifesciences and IIFL Finance. Meanwhile, HDFC Mutual Fund and BNP Paribas Arbitrage bought shares worth Rs 94 crore and Rs 51 crore in Eric Lifesciences and CEAT.